C/EBPβ expression is an independent predictor of overall survival in breast cancer patients by MHCII/CD4-dependent mechanism of metastasis formation.

作者: E Kurzejamska , J Johansson , K Jirström , V Prakash , S Ananthaseshan

DOI: 10.1038/ONCSIS.2014.38

关键词:

摘要: CCAAT-enhancer binding protein β (C/EBPβ) is a transcription factor that has critical role in mammary gland development and breast cancer progression. Loss of C/EBPβ increases metastatic dissemination mouse tumor cells. However, the mechanism by which expression affects metastasis formation remains unknown. This study aims at determining relationship between survival patients, elucidating C/EBPβ's link with formation. was evaluated 137 cases human cancer, correlation overall estimated Kaplan–Meier analysis. Additionally, 4T1 model used for vivo studies. Decreased found to be associated shorter patients. In murine model, loss growth, morphology promotes spread lungs. Immunohistochemical analyses showed inhibition leads increased major histocompatibility complex II (MHCII) expression, followed accumulation CD45-, CD3- CD4-positive (CD4+) lymphocytes tumors. Inflammation involvement C/EBPβ-mediated confirmed DNA microarray experiments on CD4+ cell-deprived nude mice. anti-CD3 anti-CD4 treatments C/EBPβ-silenced tumor-bearing mice resulted reverting effect growth metastasis. Altogether, predictor lung model. The involves immunologic response depending activation MHCII tumor.

参考文章(34)
Cynthia A. Zahnow, Robert D. Cardiff, Jeffrey M. Rosen, Daniel Medina, Rodolfo Laucirica, A Role for CCAAT/Enhancer Binding Protein β-Liver-enriched Inhibitory Protein in Mammary Epithelial Cell Proliferation Cancer Research. ,vol. 61, pp. 261- 269 ,(2001)
Luciana Benevides, Cristina RB Cardoso, Daniel G Tiezzi, Heitor RC Marana, Jurandyr M Andrade, João S Silva, None, Enrichment of regulatory T cells in invasive breast tumor correlates with the upregulation of IL-17A expression and invasiveness of the tumor European Journal of Immunology. ,vol. 43, pp. 1518- 1528 ,(2013) , 10.1002/EJI.201242951
Sergei Kusmartsev, Srinivas Nagaraj, Dmitry I. Gabrilovich, Tumor-Associated CD8+ T Cell Tolerance Induced by Bone Marrow-Derived Immature Myeloid Cells Journal of Immunology. ,vol. 175, pp. 4583- 4592 ,(2005) , 10.4049/JIMMUNOL.175.7.4583
Lisa M. Coussens, Zena Werb, Inflammation and cancer Nature. ,vol. 420, pp. 860- 867 ,(2002) , 10.1038/NATURE01322
Jumpei Homma, Ryuya Yamanaka, Naoki Yajima, Naoto Tsuchiya, Nobuyuki Genkai, Masakazu Sano, Ryuichi Tanaka, Increased expression of CCAAT/enhancer binding protein beta correlates with prognosis in glioma patients. Oncology Reports. ,vol. 15, pp. 595- 601 ,(2006) , 10.3892/OR.15.3.595
Wei Tan, Weizhou Zhang, Amy Strasner, Sergei Grivennikov, Jin Q. Cheng, Robert M. Hoffman, Michael Karin, Tumour-infiltrating regulatory T cells stimulate mammary cancer metastasis through RANKL–RANK signalling Nature. ,vol. 470, pp. 548- 553 ,(2011) , 10.1038/NATURE09707
J Johansson, T Berg, E Kurzejamska, M-F Pang, V Tabor, M Jansson, P Roswall, K Pietras, M Sund, P Religa, J Fuxe, MiR-155-mediated loss of C/EBPβ shifts the TGF-β response from growth inhibition to epithelial-mesenchymal transition, invasion and metastasis in breast cancer. Oncogene. ,vol. 32, pp. 5614- 5624 ,(2013) , 10.1038/ONC.2013.322
Y Min, S Ghose, K Boelte, J Li, L Yang, P C Lin, C/EBP-δ regulates VEGF-C autocrine signaling in lymphangiogenesis and metastasis of lung cancer through HIF-1α Oncogene. ,vol. 30, pp. 4901- 4909 ,(2011) , 10.1038/ONC.2011.187
Teizo Yoshimura, O. M. Zack Howard, Toshihiro Ito, Masaki Kuwabara, Akihiro Matsukawa, Keqiang Chen, Ying Liu, Mingyong Liu, Joost J. Oppenheim, Ji Ming Wang, Monocyte Chemoattractant Protein-1/CCL2 Produced by Stromal Cells Promotes Lung Metastasis of 4T1 Murine Breast Cancer Cells PLoS ONE. ,vol. 8, pp. e58791- ,(2013) , 10.1371/JOURNAL.PONE.0058791